1. Home
  2. Stocks
  3. Jublpharma Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Jubilant Pharmova Share Price Jubilant Pharmova

    Mid Cap
    ₹665.00
    -35.7 (-5.09%)
    20 April, 2024 07:11 BSE: 530019 NSE: JUBLPHARMAISIN: INE700A01033

    Start SIP in Jubilant Pharmova

    Start SIP

    Jubilant Pharmova Performance

    Day Range

    • Low 655
    • High 701
    ₹ 665

    52 Week Range

    • Low 299
    • High 724
    ₹ 665
    • Open Price701
    • Previous Close701
    • Volume1015524

    Jubilant Pharmova Share Price

    • Over 1 Month +17.18%
    • Over 3 Month +16.08%
    • Over 6 Month +63.75%
    • Over 1 Year +114.52%

    Jubilant Pharmova Key Statistics

    P/E Ratio 279.8
    PEG Ratio -4.6
    Market Cap Cr 10,592
    Price to Book Ratio 2
    EPS 3.1
    Dividend 0.8
    Relative Strength Index 62.92
    Money Flow Index 80.28
    MACD Signal 19.24
    Average True Range 28.88
    Jubilant Pharmova Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 170186204189
    Operating Expenses Qtr Cr 176186213198
    Operating Profit Qtr Cr -1142
    Depreciation Qtr Cr 12121111
    Interest Qtr Cr 8766
    Tax Qtr Cr 01030
    Net Profit Qtr Cr -202-31
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 948
    Operating Expenses Annual Cr 807
    Operating Profit Annual in Cr 3
    Depreciation Cr 43
    Interest Annual Cr 19
    Tax Annual Cr 29
    Net Profit Annual Cr 50
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr -65
    Cash from Investing Activity Annual Cr 31
    Cash from Financing Annual Activity Cr 23
    Net Cash Flow Annual Cr -12
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 2,415
    Fixed Assets Annual Cr 734
    Total Non Current Assets Annual Cr 2,430
    Total Current Assets Annual Cr 579
    Total Assets Annual Cr 3,008
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 152
    ROE Annual % 2
    ROCE Annual % 4
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 17
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,6651,6671,5671,661
    Operating Expenses Qtr Cr 1,4591,4391,4171,459
    Operating Profit Qtr Cr 218242170219
    Depreciation Qtr Cr 959790271
    Interest Qtr Cr 71666256
    Tax Qtr Cr 35361914
    Net Profit Qtr Cr 67636-98
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 6,320
    Operating Expenses Annual Cr 5,505
    Operating Profit Annual in Cr 776
    Depreciation Cr 554
    Interest Annual Cr 188
    Tax Annual Cr 93
    Net Profit Annual Cr -61
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 661
    Cash from Investing Activity Annual Cr -544
    Cash from Financing Annual Activity Cr -157
    Net Cash Flow Annual Cr -40
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 5,399
    Fixed Assets Annual Cr 4,316
    Total Non Current Assets Annual Cr 7,394
    Total Current Assets Annual Cr 3,762
    Total Assets Annual Cr 11,157
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 339
    ROE Annual % -1
    ROCE Annual % 3
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 13
    Sign Up to Know More
    Invest in Jubilant Pharmova

    Jubilant Pharmova Technicals

    EMA & SMA

    Current Price
    ₹665.00
    -35.7 (-5.09%)
    pointer
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹628.10
    • 50 Day
    • ₹596.21
    • 100 Day
    • ₹558.68
    • 200 Day
    • ₹505.89
    • 20 Day
    • ₹614.32
    • 50 Day
    • ₹592.93
    • 100 Day
    • ₹558.95
    • 200 Day
    • ₹486.37

    Jubilant Pharmova Resistance and Support

    PIVOT
    ₹673.54
    Resistance
    First Resistance 692.07
    Second Resistance 719.13
    Third Resistance 737.67
    RSI 62.92
    MFI 80.28
    MACD Single Line 19.24
    MACD 26.36
    Support
    First Resistance 646.47
    Second Resistance 627.93
    Third Resistance 600.87

    Jubilant Pharmova Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,082,819 55,570,271 51.32
    Week 1,253,790 41,212,061 32.87
    1 Month 759,022 22,975,604 30.27
    6 Month 626,508 25,292,125 40.37

    Jubilant Pharmova Result Highlights

    Jubilant Pharmova Synopsis

    NSE-Medical-Diversified

    Jubilant Pharmova is involved in the business activities of Manufacture of basic chemicals. Company’s Total Operating Revenue is Rs. 810.12 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2023. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
    Market Cap 10,592
    Sales 779
    Shares in Float 7.80
    No of funds 149
    Yield 0.74
    Book Value 4.4
    U/D Vol ratio 1.4
    LTDebt / Equity 7
    Alpha 0.14
    Beta 1.56

    Jubilant Pharmova

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 50.68%50.68%50.68%50.68%
    Mutual Funds 2.27%1.5%0.42%0.41%
    Insurance Companies
    Foreign Portfolio Investors 19.06%20.29%23.2%23.2%
    Financial Institutions/ Banks
    Individual Investors 18.72%18.75%18.24%18.25%
    Others 9.27%8.78%7.46%7.46%

    Jubilant Pharmova Management

    Name Designation
    Mr. Shyam S Bhartia Chairman
    Mr. Hari S Bhartia Co-Chairman
    Mr. Priyavrat Bhartia Managing Director
    Mr. Arjun Shanker Bhartia Joint Managing Director
    Mr. Arvind Chokhany WholeTime Director & Group CFO
    Mr. R Kumar Whole Time Director
    Mr. Vivek Mehra Independent Director
    Mr. Sushil Kumar Roongta Independent Director
    Mr. Arun Seth Independent Director
    Ms. Sudha Pillai Independent Director
    Dr. Ashok Misra Independent Director
    Mr. S Sridhar Independent Director
    Mr. Shirish G Belapure Independent Director

    Jubilant Pharmova Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Jubilant Pharmova Corporate Action

    Date Purpose Remarks
    2024-02-02 Quarterly Results
    2023-10-27 Quarterly Results
    2023-07-19 Quarterly Results
    2023-05-29 Audited Results & Final Dividend
    2023-02-03 Quarterly Results
    Date Purpose Remarks
    2023-08-10 FINAL Rs.5.00 per share(500%)Final Dividend
    2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
    2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

    Jubilant Pharmova MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 17,349
    Nippon India Pharma Fund - Growth 7,125
    Quant Flexi Cap Fund Growth 4,617
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,093
    HDFC Pharma and Healthcare Fund Regular Growth 801

    Jubilant Pharmova FAQs

    What is Share Price of Jubilant Pharmova ?

    Jubilant Pharmova share price is ₹665 As on 20 April, 2024 | 06:57

    What is the Market Cap of Jubilant Pharmova ?

    The Market Cap of Jubilant Pharmova is ₹10592.2 Cr As on 20 April, 2024 | 06:57

    What is the P/E ratio of Jubilant Pharmova ?

    The P/E ratio of Jubilant Pharmova is 279.8 As on 20 April, 2024 | 06:57

    What is the PB ratio of Jubilant Pharmova ?

    The PB ratio of Jubilant Pharmova is 2 As on 20 April, 2024 | 06:57

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.